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Established fear-related memories can undergo phenomena such as extinction or
reconsolidation when recalled. Extinction probably involves the creation of a new,
competing memory trace that decreases fear expression, whereas reconsolidation can
mediate memory maintenance, updating, or strengthening. The factors determining
whether retrieval will initiate extinction, reconsolidation, or neither of these two processes
include training intensity, duration of the retrieval session, and age of the memory.
However, previous studies have not shown that the same behavioral protocol can be
used to induce either extinction or reconsolidation and strengthening, depending on
the pharmacological intervention used. Here we show that, within an experiment that
leads to extinction in control rats, memory can be strengthened if rolipram, a selective
inhibitor of phosphodiesterase type 4 (PDE4), is administered into the dorsal hippocampus
immediately after retrieval. The memory-enhancing effect of rolipram lasted for at least
1 week, was blocked by the protein synthesis inhibitor anisomycin, and did not occur
when drug administration was not paired with retrieval. These findings indicate that
the behavioral outcome of memory retrieval can be pharmacologically switched from
extinction to strengthening. The cAMP/protein kinase A (PKA) signaling pathway might
be a crucial mechanism determining the fate of memories after recall.
Keywords: phosphodiesterase 4, rolipram, extinction, reconsolidation, hippocampus, inhibitory avoidance, fear
memory
INTRODUCTION
Newly formed memory traces become increasingly resistant to
disruption or enhancement by different types of interference,
through the process known as consolidation (McGaugh, 2000).
However, the retrieval of a previously consolidated memory can
lead to phenomena such as extinction, which is likely based on the
formation of a new memory that weakens the expression of the
original learning (Bouton and Bolles, 1979; Quirk and Mueller,
2008), and reconsolidation, a process involving labilization fol-
lowed by a new phase of stabilization, that may serve to maintain,
update, or strengthen the memory trace (Nader et al., 2000;
Sara, 2000a; Alberini, 2011). Extinction and reconsolidation are
usually viewed as two opposing and possibly competing processes
triggered by retrieval, resulting in long-lasting modifications of
the original memory trace, or at least of its behavioral expression.
The factors determining whether extinction, reconsolidation
accompanied by strengthening, or neither of these processes will
be initiated by retrieval remain poorly understood. Studies have
found that manipulations of training intensity, retrieval duration,
and age of the memory can be used to guide memory retrieval
towards extinction or reconsolidation. For example, the use of
longer retrieval sessions led to extinction, while a shorter exposure
to the learning environment during retrieval induces labilization
and sensitivity to drug interference (Pedreira and Maldonado,
2003; Suzuki et al., 2004; Lee et al., 2006). In addition, retrieval
more likely results in reconsolidation-mediated strengthening
when the original memory is younger or more robust (Eisenberg
et al., 2003; Inda et al., 2011). Thus, some of the behavioral
training and testing conditions that allow for the discrimination
between extinction and reconsolidation have been characterized.
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However, previous studies have not shown whether purely
pharmacological, biochemical, or molecular factors can act as
switches determining the occurrence of extinction or reconsol-
idation upon retrieval. Here we investigated the effect of post-
retrieval phosphodiesterase type 4 (PDE4) inhibition in the dorsal
hippocampus on memory retention. The original aim of this
study was to examine the role of PDE4 in extinction, and our
initial hypothesis was that rolipram could accelerate extinction of
inhibitory avoidance (IA). We chose rolipram as a selective PDE4
inhibitor known to enhance hippocampal long-term potentiation
(LTP) and memory in different models (Barad et al., 1998; Tully
et al., 2003). Surprisingly, we found that, under experimental
conditions in which retrieval normally leads to extinction, this
outcome can be switched to memory strengthening by a sin-
gle intrahippocampal infusion of rolipram. To our knowledge,
this finding provides the first evidence that whether retrieval
will lead to extinction or strengthening (possibly mediated by
reconsolidation) can be influenced by manipulating cell signaling
mechanisms in the brain.
METHODS
ANIMALS
Adult male Wistar rats (310–400 g of weight, around 90 days
of age at time of surgery) were obtained from the institutional
breeding facility (CREAL, ICBS, UFRGS, Porto Alegre, Brazil)
and the State Health Science Research Foundation (FEPPS-RS,
Porto Alegre, Brazil). Animals were housed five per cage in
plastic cages with sawdust bedding, and maintained on a 12 h
light/dark cycle at a room temperature of 22 ± 1 C. The rats
were allowed ad libitum access to standardized pellet food and
water. All experiments took place between 9 AM and 6 PM. All
experimental procedures were performed in accordance with the
National Institutes of Health (NIH) Guide for the Care and Use
of Laboratory Animals and were approved by the institutional
animal care committee (CEUA-HCPA 05-519).
SURGERY
Animals were implanted under anesthesia with ketamine
(75 mg/kg) and xylazine (25 mg/kg) with bilateral 14-mm or
9.0-mm, 23-gauge guide cannulae aimed 1.0 mm above the CA1
area of the dorsal hippocampus, as described in previous studies
(Roesler et al., 2006; Jobim et al., 2012). Coordinates antero-
posterior, −4.3 mm from bregma; mediolateral, ±3.0 mm from
bregma; ventral,−2.0 mm from skull surface) were obtained from
the atlas of Paxinos and Watson (2007). Animals were allowed to
recover for at least 7 days after surgery.
DRUGS AND INFUSION PROCEDURES
The general procedures for intra-hippocampal infusions were as
described in previous reports (Quevedo et al., 1999; Luft et al.,
2006; Roesler et al., 2006). At the time of infusion, a 30-gauge
infusion needle was fitted into the guide cannula. The tip of the
infusion needle protruded 1.0 mm beyond the guide cannula
and was aimed at the CA1 area of the dorsal hippocampus.
The animals received, via the infusion cannula, a bilateral 0.8 µl
infusion of vehicle (20% dimethylsulfoxide, DMSO, in saline),
the PDE4 inhibitor rolipram (7.5 µg /side dissolved in vehicle;
Sigma-Aldrich, St. Louis, USA), the protein synthesis inhibitor
anisomycin (80.0 µg/side dissolved in vehicle; Sigma-Aldrich,
St. Louis, USA), or rolipram combined with anisomycin at the
doses described above. Drug doses were chosen on the basis of
previous studies (Quevedo et al., 1999; Vianna et al., 2001; Luft
et al., 2006; Werenicz et al., 2012). Drug or vehicle was infused
over a 30-s period. Solutions were freshly prepared before each
experiment.
In different experiments, intra-hippocampal infusions were
given immediately after the first retrieval session (which also
served as extinction training), 1 h after retrieval (delayed infusion
controls), 24 h after training in the absence of retrieval (no
retrieval controls), or immediately after training.
INHIBITORY AVOIDANCE
We used the single-trial step-down IA task as an established
model of fear memory. In step-down IA training, animals learn
to associate a location in the training apparatus (a grid floor)
with an aversive stimulus (footshock). The general procedures for
IA behavioral training and retention tests have been described in
previous reports (Quevedo et al., 1999; Luft et al., 2006; Jobim
et al., 2012). The IA apparatus was a 50× 25× 25-cm acrylic box
(Albarsch, Porto Alegre, Brazil) whose floor consisted of parallel
caliber stainless steel bars (1 mm diameter) spaced 1 cm apart. A
7-cm wide, 2.5-cm high platform was placed on the floor of the
box against the left wall.
On training trials, rats were placed on the platform and
their latency to step down on the grid with all four paws was
measured with a digital chronometer connected to the box con-
trol unit. Immediately after stepping down on the grid, rats
received a mild footshock (0.5-mA, 2.0-s) and were removed
from the apparatus immediately afterwards. Retention test tri-
als (retrieval sessions also serving as extinction training trials)
took place at different time points after training by placing
the rats on the platform and recording their latencies to step
down. No footshock was presented during retention test trials.
In trials in which post-retrieval drug infusions were given, rats
that did not step down to the grid floor within 180 s were led
by the experimenter to step down on the grid floor for 3 s.
Step-down latencies on the retention test trial (maximum 180
s) were used as a measure of IA memory retention. In some
of the experiments, rats showing extinction were given a 0.2-
mA, 2.0-s reminder footshock at the end of the series of testing
sessions (Tronel and Alberini, 2007), followed by an additional
retention test 24 h later. It should be mentioned that this is
a collaborative experiment in which two identical IA training
apparatuses in two different laboratories were used for different
experiments.
HISTOLOGY
Twenty-four to 72 h after behavioral testing, a 0.5-µl infusion of a
4% methylene blue solution was given into the dorsal hippocam-
pus. Rats were sacrificed by decapitation 15 min later, and their
brains were removed and stored in 10% formalin for at least 72 h.
The brains were sectioned and examined for cannulae placement
in the hippocampus. The extension of the methylene blue dye was
taken as indicative of diffusion of the drugs given to each rat.
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Animals included in the final analysis (146 rats) had bilaterally
placed cannula in the intended sites. Infusion placements into the
dorsal hippocampus, as revealed by the diffusion of methylene
blue, was similar to those described in previous reports (Quevedo
et al., 1999; Roesler et al., 2006, 2009; Jobim et al., 2012; data not
shown).
STATISTICS
Data are shown as mean ± S.E.M. retention test latencies to
step-down (s). Comparisons of training and retention test step-
down latencies between groups were performed using Kruskal-
Wallis analysis of variance followed by Mann-Whitney U-tests,
two-tailed, when appropriate. Comparisons between behavioral
sessions within the same group were made using Friedman tests.
Nonparametric tests were chosen because of the ceiling cutoff
imposed to retention test latencies (Quevedo et al., 1999; Vianna
et al., 2001; Luft et al., 2006; Roesler et al., 2006; Jobim et al.,
2012). In all comparisons, P < 0.05 was considered to indicate
statistical significance.
RESULTS
ADMINISTRATION OF ROLIPRAM INTO THE DORSAL HIPPOCAMPUS
AFTER RETRIEVAL SWITCHES MEMORY FROM EXTINCTION TO
STRENGTHENING
In the first experiment, we examined the effect of an intrahip-
pocampal administration of rolipram immediately after IA mem-
ory retrieval, using a protocol that induces extinction in control
rats (Vianna et al., 2001). The experimental design is shown in
Figure 1A. Rats were trained in IA and underwent a retrieval
session (Test 1, which also acted as extinction training) 24 h
later. Immediately after retrieval, animals were infused with
vehicle (N = 9), rolipram (N = 10), anisomycin (N = 9), or
rolipram combined with anisomycin (N = 10). Animals were
tested again 48 h (Test 2) and 72 h (Test 3) after Test 1. Rats
infused with vehicle also received a mild 2.0-s reminder foot-
shock (0.2 mA) immediately upon stepping down on Test 3,
and were given an additional test trial 24 h after Test 3 (“Rein-
statement”), as a procedure used to confirm that the decrease in
latencies across trials was due to extinction (Tronel and Alberini,
2007).
Results are shown in Figure 1B. A Kruskal-Wallis analysis of
variance showed significant differences among groups in Test 3
(H = 17.3, df = 3, P < 0.01), but not in any other behavioral
session (Training, H = 2.3, df = 3, P = 0.52; Test 1, H =
2.60, df = 3, P = 0.46; Test 2, H = 4.3, df = 3, P = 0.23).
Further analysis with Mann-Whitney tests showed that rats given
rolipram or anisomycin (Ps < 0.01), or rolipram combined
with anisomycin (P < 0.05) had latencies in Test 3 that were
significantly higher than those in control rats given vehicle. Rats
infused with rolipram alone had higher Test 3 latencies compared
to rats given anisomycin or rolipram combined with anisomycin
(Ps < 0.05). In control rats given vehicle, retention test laten-
cies progressively declined across test trials, indicating memory
extinction. A Friedman test showed a significant decrease in
latencies across test trials (H = 13.8, df = 2, P < 0.01). Step-
down latencies in this group went back to the levels observed
in Test 1 in the “Reinstatement” test trial following a reminder
FIGURE 1 | The PDE4 inhibitor rolipram switches memory for IA from
extinction to strengthening when given into the hippocampus
immediately after retrieval. Rats were given an IA training trial followed
24 h later by a retrieval session (Test 1), which also served as an extinction
training trial. Immediately after Test 1, animals were infused into the dorsal
hippocampus with vehicle (N = 9), rolipram (7.5 µg/side, N = 10),
anisomycin (80.0 µg/side, N = 9), or rolipram combined with anisomycin
(N = 10). Retention test trials were carried out 48 (Test 2) and 72 h (Test 3)
after Test 1. Vehicle-treated rats received a mild reminder footshock
(0.2 mA) immediately upon stepping down on Test 3, and were given an
additional test trial 24 h later (“Reinstatement”). (A) Schematic diagram
showing the experimental design. (B) Rats given vehicle showed extinction
of IA memory, whereas rolipram-treated rats showed memory
strengthening, across test trials. The protein synthesis inhibitor anisomycin
prevented both extinction and rolipram-induced strengthening; * P < 0.05,
** P < 0.01 compared to the vehicle group within the same test trial;
## P < 0.01 compared to Test 1 within the same group.
shock, consistent with what would be expected for memory
extinction. In contrast, rats infused with rolipram showed a
progressive enhancement of IA retention across test trials (com-
parison among all three test trials using a Friedman test, H
= 9.5, df = 2, P < 0.01). There were no differences between
test trials within the groups treated with either anisomycin or
rolipram combined with anisomycin (comparison among all
three test trials using a Friedman test, anisomycin, H = 1.4,
df = 2, P = 0.49; rolipram plus anisomycin, H = 4.2, df = 2,
P = 0.12).
These results indicate that (1) in rats trained and tested in
a protocol that induces extinction, intrahippocampal rolipram
caused memory strengthening rather than extinction to occur
after retrieval, and (2) blocking protein synthesis in the dorsal
hippocampus prevented both extinction in vehicle-treated rats
and the rolipram-induced retention strengthening in animals
receiving the drug.
MEMORY ENHANCEMENT BY POST-RETRIEVAL ADMINISTRATION OF
ROLIPRAM REQUIRES RECALL
The second experiment was a “no retrieval control” in which we
verified whether retrieval was necessary for the memory facilita-
tion induced by rolipram. Rats were infused with vehicle (N =
13), rolipram (N = 12), anisomycin (N = 7), or anisomycin plus
rolipram (N = 9), 24 h after training in the absence of a retrieval
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FIGURE 2 | No retrieval control. Rats were trained in IA and 24 h later
received an intrahippocampal infusion of vehicle (N = 13), rolipram (7.5
µg/side, N = 12), anisomycin (80.0 µg/side N = 7), or anisomycin plus
rolipram (N = 9), in the absence of a retrieval session. Retention test trials
were carried out at both 48 (Test 1) and 72 h (Test 2) after infusion.
(A) Schematic diagram showing the experimental design. (B) Latencies to
step-down during IA behavioral trials. There were no significant differences
among groups.
trial (Figure 2A). Rats were tested for retention at both 48 h (Test
1) and 72 h (Test 2) after infusion. There were no significant
differences among groups (Kruskal-Wallis test, Training, H = 2.9,
df = 3, P = 0.41; Test 1, H = 1.0, df = 3, P = 0.80; Test 2, H = 2.0,
df = 3, P = 0.56; Figure 2B). These results confirm that the drug
infusion needs to be paired with retrieval in order for rolipram to
enhance memory.
DELAYED POST-RETRIEVAL ADMINISTRATION OF ROLIPRAM INTO THE
HIPPOCAMPUS DOES NOT AFFECT MEMORY
Rolipram had no effect when the intrahippocampal infusion was
given 1 h after retrieval measured at Test 1 (“delayed infusion
control”), indicating that PDE4 inhibition can modulate memory
strengthening specifically at an early time period after retrieval
(Figure 3). Rats were trained and tested as in the first experiment.
Mann-Whitney tests showed no significant differences between
groups (Training, P = 0.88; Test 1, P = 0.72; Test 2, P = 0.72; Test
3, P = 0.42; N = 8 rats per group).
THE MEMORY-ENHANCING EFFECT OF INTRAHIPPOCAMPAL
ROLIPRAM GIVEN AFTER RETRIEVAL LASTS FOR AT LEAST 1 WEEK
In order to examine the persistence of the memory-enhancing
effect of post-retrieval rolipram, rats were trained as before and
tested at 24 h (Test 1), 72 h (Test 2), 96 h (Test 3), and 7
days (Test 4) later. Vehicle (N = 10) or rolipram (N = 9) was
infused immediately after Test 1 (Figure 4A). Mann-Whitney
tests showed significant differences between groups in Test 3
(P < 0.05) and Test 4 (P < 0.01), but not in Training (P =
0.97), Test 1 (P = 0.55), or Test 2 (P = 0.13). Control rats,
but not rats given rolipram, showed a significant decrease in
FIGURE 3 | Delayed infusion control. Rats were given an IA training trial
followed 24 h later by a retrieval/extinction session (Test 1). 1 h after Test 1,
animals were infused into the dorsal hippocampus with vehicle or rolipram
(7.5 µg/side, N = 8 rats per group). Retention test trials were carried out 48
(Test 2) and 72 h (Test 3) later. (A) Schematic diagram showing the
experimental design. (B) Latencies to step-down during IA behavioral trials.
There were no significant differences among groups.
FIGURE 4 | Persistence of the memory enhancement induced by
rolipram administration after retrieval. Rats were given an IA training trial
followed by retention test trials at 24 h (Test 1), 72 h (Test 2), 96 h (Test 3),
and 7 days (Test 4) later. Vehicle (N = 10) or rolipram (7.5 µg/side, N = 9)
was infused immediately after Test 1. (A) Schematic diagram showing the
experimental design. (B) Vehicle-treated rats showed extinction of IA
memory, whereas rats infused with rolipram showed memory
strengthening, across test trials; * P < 0.05, ** P < 0.01 compared to the
vehicle group within the same behavioral trial; # P < 0.05 compared to Test
1 within the same group.
latencies across test trials (Friedman test, comparison across
tests trials, H = 8.4, df = 3, P < 0.05) (Figure 4B). The
results indicate that the enhancing effect of intrahippocampal
rolipram given immediately after retrieval can last for at least
1 week.
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FIGURE 5 | Neither rolipram nor anisomycin affect IA memory
formation when infused into the hippocampus immediately after
training. Rats were given an IA training trial followed 48 h later by a test
trial. An intrahippocampal infusion of vehicle (N = 11), rolipram (7.5 µg/side,
N = 12) or anisomycin (80.0 µg/side, N = 9) was given immediately after
training. (A) Schematic diagram showing the experimental design. (B)
Latencies to step-down during IA behavioral trials. There were no significant
differences among groups.
ADMINISTRATION OF ROLIPRAM INTO THE HIPPOCAMPUS
IMMEDIATELY AFTER TRAINING DOES NOT AFFECT MEMORY
CONSOLIDATION
In the last experiment, we verified whether rolipram and ani-
somycin could also affect IA memory consolidation. Vehicle (N =
11), rolipram (N = 12) or anisomycin (N = 9) was infused into the
hippocampus immediately after training, and retention was tested
48 h later. Results are shown in Figure 5. There were no differences
between groups in Training (Kruskal Wallis test, Training,H = 3.8,
df = 2, P = 0.15; Test, H = 4.2, df = 2, P = 0.12). The result suggests
that neither rolipram nor anisomycin affected the consolidation
phase of memory when given early after training.
DISCUSSION
Recall of a fear-motivated memory can lead to extinction, which
likely involves the creation of a second memory trace that
decreases fear expression (Quirk and Mueller, 2008). Alterna-
tively, retrieval can induce the labilization of the original memory,
which again becomes sensitive to interference, a process usually
referred to as reconsolidation. It has been proposed that recon-
solidation can serve to maintain, update, or alter the strength of
memories (Sara, 2000a,b; Amaral et al., 2008; Lee, 2008, 2010;
Alberini, 2011; Alberini and Ledoux, 2013; de Oliveira Alvares
et al., 2013; Reichelt and Lee, 2013).
Several studies have shown that whether a retrieved memory
will undergo extinction or reconsolidation depends on the condi-
tions under which the memory is learned and reactivated, factors
that are generally manipulated experimentally by altering the
training intensity, retrieval session duration, or intervals between
behavioral trials (Eisenberg et al., 2003; Pedreira and Maldonado,
2003; Suzuki et al., 2004; Lee et al., 2006; Inda et al., 2011; Flavell
and Lee, 2013). Here, we show that, within an experimental con-
dition that promotes extinction in control rats, inhibiting PDE4 in
the dorsal hippocampus can alter the fate of the memory towards
strengthening. Both extinction and rolipram-induced strengthen-
ing depend on protein synthesis, since infusion with anisomycin
blocked both processes. Control experiments omitting the first
retrieval trial or using delayed and posttraining infusions indi-
cate that the effects were not due to long-lasting drug-induced
alterations in locomotion, motivation, anxiety, sensory function,
or other nonspecific factors. To our knowledge, this is the first
direct demonstration of a pharmacologically-inducible “switch”
between memory extinction and reconsolidation.
Although most studies on reconsolidation have focused on the
disruption of recalled memories by administration of amnestic
agents, there is previous evidence that some drug treatments
can enhance retention when paired with retrieval. Early studies
showed that systemic injections of strychnine after retrieval could
enhance IA memory in rats (Gordon, 1977). More recently,
memories for fear conditioning in rats have been shown to be
enhanced by post-retrieval administration of drugs including the
protein kinase A (PKA) activator 6-BNZ-cAMP infused into the
basolateral amygdala (BLA; Tronson et al., 2006), the partial
N-methyl-D-aspartate (NMDA) receptor agonist D-cycloserine
injected systemically (Lee et al., 2006), or the CB1 cannabinoid
receptor antagonist AM251 infused into the dorsal hippocampus
(de Oliveira Alvares et al., 2008). However, in all previous studies,
the experimental conditions used were such that control rats did
not show significant extinction across test trials.
Memory strengthening has been observed after either rein-
forced (i.e., with additional training) or non-reinforced (retrieval
alone in the absence of a reinforcing stimulus) re-exposure to
the learning context (Roesler et al., 1998, 2000; Quevedo et al.,
1999; Lee, 2008; Roesler and Quevedo, 2009; Inda et al., 2011;
Pedroso et al., 2013; Reichelt and Lee, 2013). Since strengthening
depends critically on retrieval of the original memory (Roesler
and Quevedo, 2009), and requires molecular mechanisms in
the hippocampus that specifically underlie reconsolidation (Lee,
2008), is has been proposed that reconsolidation is the mechanism
mediating strengthening (Lee, 2008; Alberini and Ledoux, 2013).
Memory enhancement by repeated retrieval has been seen as
a possible adaptive function of reconsolidation, since it allows
relevant fear memories to be strengthened without requiring re-
exposure to the original aversive learning experience (Alberini
and Ledoux, 2013). It should be noted, however, that our findings
do not clearly allow us to exclude the possibility that mechanisms
other than reconsolidation mediate memory strengthening. One
argument against the possibility of reconsolidation in this case
is the fact that the latencies of animals treated with rolipram
combined with anisomycin were similar between Test 2 and Test
1, suggesting that anisomycin selectively blocked the rolipram-
induced enhancement without affecting the original memory.
Thus, rolipram could be inducing a condition in which memory
reinforcement occurs without labilization of the original memory
(Osan et al., 2011; Pedroso et al., 2013). However, it should be
noted that reconsolidation blockade with post-retrieval intrahip-
pocampal anisomycin has not been consistently demonstrated in
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the step-down IA task (Vianna et al., 2001). Moreover, a slight
trend for decreased latencies across the 3 test trials was observed
in rats receiving rolipram and anisomycin, although this did not
reach statistical significance. Thus, our data do not exclude the
possibility that reconsolidation-like mechanisms are involved in
the memory strengthening effect observed.
It has been hypothesized that high levels of attention or
arousal during retrieval could reinforce the memory trace through
endogenous mechanisms that might involve increased release of
modulators such as catecholamines (Sara, 2000b). This possibility
is consistent with the studies mentioned above showing that drugs
that stimulate modulatory pathways can enhance memory when
given shortly after retrieval. The findings reported by Tronson
et al. (2006) showing strengthening of fear conditioning mem-
ory by a PKA activator after retrieval are particularly relevant
for comparison with our present results, since PDE4 inhibitors
such as rolipram enhance memory by increasing neuronal lev-
els of cAMP, thus ultimately activating the cAMP/PKA/cAMP
response-element binding protein (CREB) pathway (Barad et al.,
1998; Bach et al., 1999; Bourtchouladze et al., 2003; Tully et al.,
2003; Gong et al., 2004; de Lima et al., 2008). Further support
for a crucial role of cAMP/PKA/CREB signaling in promoting
memory strengthening upon retrieval has been provided by
recent evidence that the experimentally-induced activation of
amygdalar neurons expressing elevated CREB was sufficient to
induce the recall of an established fear memory and promote a
reconsolidation-like reorganization process leading to memory
strengthening (Kim et al., 2014). The cAMP/PKA/CREB pathway
is a particularly promising candidate mechanism regulating the
fate of memories during retrieval, since it is crucially involved
in memory formation and mediates the actions of many endoge-
nous modulators of emotional memory, including dopamine and
norepinephrine (Abel et al., 1997; Bevilaqua et al., 1997; Bach
et al., 1999; Tully et al., 2003; Quevedo et al., 2004; Roesler and
Schröder, 2011).
In previous studies using IA, we found that similar retrieval
conditions could result in memory extinction (Luft et al., 2006),
reconsolidation sensitive to impairment by mTOR inhibition
(Jobim et al., 2012), or protein-synthesis dependent, retrieval-
induced, memory strentgthening (Pedroso et al., 2013). However,
the behavioral and neurochemical factors determining these
different outcomes of retrieval remain elusive. According to
the “trace dominance” model, the result of a retrieval ses-
sion/extinction trial involves the sum of multiple and conflicting
processes, including a competition between the original excita-
tory memory trace and a new inhibitory extinction trace, for
the control of behavior (Eisenberg et al., 2003). More recent
computational work has proposed that network dynamics can
lead to strengthening without labilization, reconsolidation or
extinction depending on the degree of mismatch between the
original memory and the retrieval session (Osan et al., 2011).
Nevertheless, the current results indicate that the definition of the
dominant process during retrieval can be altered by pharmaco-
logical manipulation of the hippocampus.
The present findings indicate that PDE4 inhibition, presum-
ably by enhancing cAMP signaling, can shift the balance between
the processes occurring during retrieval, directing a recalled
memory in a way that favors strengthening rather than extinction.
In this sense, it is interesting to note that, in fear conditioning,
some data suggest that hippocampal and prefrontal inputs con-
verge on the amygdala, with the former driving fear expression
and reconsolidation and the latter favoring extinction (Herry
et al., 2008; Mamiya et al., 2009). It is possible that stimulating
neuronal populations responsible for the representation of the
fear memory in the hippocampus through manipulation of the
AMPc/PKA/CREB cascade could shift this balance in favor of
hippocampal inputs driving maintenance and strengthening of
the original memory. This hypothesis should be further examined
by future experiments.
Although both protein synthesis and PKA activity in the dorsal
hippocampus are required for memory formation, we did not find
effects of rolipram or anisomycin when infused after learning.
However, previous reports have indicated that intra-hippocampal
anisomycin can impair IA memory consolidation when given
before or 3 h after, but not immediately after training (Quevedo
et al., 1999). Also, drugs acting on the PKA pathway have been
shown to influence IA memory consolidation only when infused
into the hippocampus 3 h posttraining (Bevilaqua et al., 1997).
Thus, the reason for the lack of effect of rolipram and anisomycin
in this case is likely to be related to temporal factors, and does
not imply that IA consolidation is independent from protein
synthesis.
In conclusion, we provide evidence suggesting that the behav-
ioral outcome of the recall of an established memory can be
pharmacologically switched from extinction towards strengthen-
ing through a purely pharmacological intervention, by pairing
retrieval with PDE4 inhibition in the dorsal hippocampus. These
findings may contribute to our understanding of the factors
governing memory modifications induced by recall.
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